Cancer patient Alamgir Hossain, 51, is set to become the first ever patient to have his bone marrow transplant done in the country, with senior officials of Dhaka Medical College Hospital (DMCH) expressing hopes that the procedure will be held in the last week of this month.
Since October 6, Alamgir, a retired army sergeant who is suffering from a form of blood cancer called multiple myeloma, has been receiving a 10-day treatment of stem cell mobilisation drugs as preparation for the bone marrow transplant (BMT), under the hematology department of DMCH.
Sources said a bone marrow transplant specialist will collect stem cell from the patient’s bone on October 17. Senior DMCH officials said the transplant procedure may be held on October 24 or 26.
To assist the transplant, three BMT experts from Massachusetts General Hospital in the US have already arrived at the DMCH, as part of a memorandum of understanding penned between the two hospitals.
On Thursday, Director of the DMCH Brigadier General Dr Mustafizur Rahman told the Dhaka Tribune: “It is true that we have been taking all sorts of preparation to do the ever first bone marrow transplant in Bangladesh at DMCH-2. The DMCH will bear all the expenses of the first transplant at free of cost.”
He said a special unit with five specialised beds and special instruments has been established on the 10th floor of DMCH-2, adding that several doctors, nurses, and technicians have taken specialised training on BMT at home and abroad.
The DMCH director also expressed hopes that the first transplant of bone marrow would be done in the last week of October.
On Thursday, the patient’s daughter Lubna Hossain told the Dhaka Tribune that her father is an ex-army personnel, hailing from Kahalpur village in Bagerhat.
Since his blood cancer was diagnosed in December 2009, Alamgir had been receiving treatment at the Combined Military Hospital, Lubna added.
It was learnt that three more patients were on the queue for next BMT procedures.
Sources said the special DMCH unit will be able to bring down the cost of the transplant to Tk500,000, compared to BMT costs of around Tk10m in the US, over Tk5m in Singapore and over Tk4m in India.
Bone marrow transplant has the potential to cure the blood disorder thalassaemia (major and minor), several types of bone cancer, and other non-malignant and non-cancerous diseases.



